3687-64-7

Usage

Uses

Used in Pharmaceutical Industry:
Galactinol Dihydrate is used as a key component in the development of drugs targeting various physiological processes. Its involvement in insulin signal transduction, cytoskeleton assembly, and nerve guidance makes it a valuable asset for creating medications that address a wide range of health issues.
Used in Nutraceutical Industry:
Galactinol Dihydrate is used as an ingredient in the development of nutraceutical products aimed at promoting overall health and well-being. Its role in serotonin activity and the breakdown of fats and cholesterol reduction makes it a beneficial addition to supplements and functional foods.
Used in Research and Development:
Galactinol Dihydrate is used as a research tool for studying the mechanisms behind various biological processes, such as insulin signal transduction and membrane potentials. Its presence in these processes allows scientists to gain a deeper understanding of the underlying molecular interactions and develop targeted therapies for various diseases.
Used in Cosmetics Industry:
Galactinol Dihydrate can be used as an active ingredient in the development of cosmetics and skincare products. Its role in nerve guidance and cytoskeleton assembly may contribute to the development of products that promote skin health and regeneration.

Upstream product

• 29971-56-0 1-O-(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-3,4,5,6-tetra-O-acetyl-sn-myo-inositol 
• 6587-77-5 1-O-(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-2,3,4,5,6-penta-O-acetyl-sn-myo-inositol 
• 87-89-8 D-myo-inositol 
• 210281-95-1 β-D-mannopyranosyl fluoride 
• 439-03-2 2,3,4,6-tetra-O-acetyl-β-D-mannopyranosyl fluoride 
• 28140-37-6 3,4,6-tri-O-acetyl-1,2-O-(1-ethoxyethylidene)-β-D-mannopyranoside 
• 26277-05-4 1,2,4,5,6-penta-O-benzyl-sn-myo-inositol 
• 57-50-1 Sucrose 
• 2956-16-3 uridine 5'-diphospho-D-galactose 
• 133-89-1 UDP-glucose 
• 319918-45-1 O-(2,3,4-tri-O-benzyl-α-D-galactopyranosyl)-(1-3)-1,2,4,5,6-penta-O-benzyl-sn-myo-inositol 

Downstream Products

• 6587-77-5 1-O-(2,3,4,6-tetra-O-acetyl-α-D-mannopyranosyl)-2,3,4,5,6-penta-O-acetyl-sn-myo-inositol 
• 4539-74-6 (2S)-penta-O-methyl-O¹-(tetra-O-methyl-α-D-galactopyranosyl)-myo-inositol 

Relevant academic research and scientific papers

Creation of an α-mannosynthase from a broad glycosidase scaffold

α-Mannosides made easy: Mutation of a family-GH31 α-glucosidase that displays plasticity to alterations at the 2-OH position of donor substrates created an efficient α-mannoside-synthesizing biocatalyst. A simple fluoride donor reagent was used for the synthesis of a range of mono-α-mannosylated conjugates using the α-mannosynthase displaying low (unwanted) oligomerization activity. Copyright

Production of galactinol from sucrose by plant enzymes.

Galactinol, 1-O-(alpha-D-galactopyranosyl)-myo-inositol, was produced from sucrose as a starting material. UDP-Glc was prepared with sucrose and UDP using sucrose synthase partially purified from sweet potato roots. Then, the UDP-Glc was converted to UDP-Gal using yeast UDP-Gal 4-epimerase from a commercial source. Finally, galactinol was produced from the UDP-Gal and myo-inositol using galactinol synthase partially purified from cucumber leaves. The product was identified as galactinol by the retention times of HPLC, alpha-galactosidase digestion, and NMR spectrometry.

Syntheses of penta-O-benzyl-myo-inositols, O-β-L-arabinosyl-(1 → 2)sn-myo-inositol, O-α-D-galactosyl-(1 → 3)-sn-myo-inositol, and O-α-D-galactosyl-(1 → 6)-O-α-D-galactosyl-(1 → 3)-sn-myo-inositol

Two-step conversions of myo-inositol into (±)-2,3,4,5,6- and 1,3,4,5,6-penta-O-benzyl-myo-inositols are described. Starting from these monohydroxy derivatives of myo-inositol, O-β-L-arabinopyranosyl-(1→2)-sn-myo-inositol from Japanese green tea, Camellia sinensis, and O-α-D-galactopyranosyl-(1→3)-sn-myo-inositol (galactinol) as well as its homolog, O-α-D-galactopyranosyl-(1→6(II))-galactinol, were synthesized by way of the in situ activating glycosylation procedure.

DERIVATIVES OF ASYMMETRICALLY SUBSTITUTED MYO-INOSITOL. XXXIII. SYNTHESIS OF DIASTEROMERIC MANNOSIDES OF MYO-INOSITOL

Diastereomeric acetylated mannosides of myo-inositol were synthesized by the glycosylation of the racemic acetates of myo-inositol with the ethyl orthoacetate of D-mannose.The synthesized mannosides of myo-inositol can be used for the production of chiral myo-inositol acetates and as intermediates in the synthesis of complex phosphoinositides.